Login
Login

Transactions

Helping to create prosperity from ambition.

March 2022

Statera Biopharma, Inc.

Nasdaq: STAB

$5,650,000

Underwritten Public Offering

Sole Bookrunner*

PRESS RELEASE

February 2022

Northern Lights Acquisition Corp.

Nasdaq: NLITU

$60,000,000

Private Placement

Exclusive Placement Agent*

PRESS RELEASE

February 2022

Alset Capital Acquisition Corp.

Nasdaq: ACAXU

$86,250,000

SPAC IPO

Sole Bookrunner*

PRESS RELEASE

February 2022

American Rebel Holdings, Inc.

Nasdaq: AREB

$10,500,000

Underwritten Public Offering and Uplisting

Sole Bookrunner*

PRESS RELEASE

February 2022

Statera Biopharma, Inc.

Nasdaq: STAB

$2,000,000

Registered Direct Offering

Exclusive Placement Agent*

PRESS RELEASE

February 2022

Evergreen Corporation

Nasdaq: EVGRU

$115,000,000

SPAC IPO

Sole Bookrunner*

PRESS RELEASE

February 2022

HNR Acquisition Corp

NYSE: HNRAU

$86,250,000

SPAC IPO

Sole Bookrunner*

PRESS RELEASE

February 2022

TC BioPharm (Holdings) PLC

Nasdaq: TCBP

$17,500,004

Initial Public Offering

Sole Bookrunner*

PRESS RELEASE

February 2022

Vivakor, Inc.

Nasdaq: VIVK

$8,000,000

Underwritten Public Offering and Uplisting

Sole Bookrunner*

PRESS RELEASE

February 2022

Splash Beverage Group, Inc.

NYSE: SBEV

$9,200,000

Underwritten Public Offering

Sole Bookrunner*

PRESS RELEASE

February 2022

Genesis Unicorn Capital Corp.

Nasdaq: GENQU

$86,250,000

SPAC IPO

Sole Bookrunner*

PRESS RELEASE

February 2022

Future Tech II Acquisition Corp.

Nasdaq: FTIIU

$115,000,000

SPAC IPO

Sole Bookrunner*

PRESS RELEASE
Disclosure

* All securities offered through a broker-dealer affiliated with the principals of E.F. Hutton & Co. LLC. All such deals were conducted through EF Hutton LLC (CRD# 103792, 2020-2024). E.F. Hutton & Co. LLC had no involvement in the transactions from 2020-2024.

Login
Multi-Level Sidebar
About Us
Divisions
Transactions
Careers
Contact Us